Symptomatic alpha-thalassemia (α-thal) as found in South-East Asia is uncommon in India. However, the presence of Hb Bart’s in cord blood samples has been reported from different parts of India and the prevalence of α-thal has ranged from 0.5 to 18% by different electrophoretic techniques. The methodology utilised has ranged from paper electrophoresis to isoelectric focussing (IEF). We screened 798 cord bloods for the presence of Hb Bart’s by cellulose acetate electrophoresis and found a prevalence rate of α-thal of 15.3% in a heterogenous population in Bombay. A comparison of four different electrophoretic techniques for detection of Hb Bart’s in 138 neonates showed that cellulose acetate and starch gel electrophoresis were by and large comparable and only a little less sensitive than IEF. Paper electrophoresis used at many centers in India was most insensitive. As α-genotyping is not possible at most centers in the country, it is suggested that a simple cellulose acetate electrophoresis would be the method of choice for screening neonates for α-thal in India. As a part of our follow-up study, α-genotyping was done by Southern blot hybridization in 24 cases who had shown variable levels of Hb Bart’s at birth. The rightward deletion (-α3.7/) either in a heterozygous or homozygous condition was the only gene defect encountered in this preliminary study. However, 7 of 24 cases (29.17%) showed no correlation between Hb Bart’s level and α-genotypes.

Keywords:
Alpha-thalassemia, Hb Bart’s, Alpha-genotypes
This content is only available via PDF.
© 1997 S. Karger AG, Basel
1997
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.